Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neckG. Catimel, Jan B. Vermorken, Martine Piccart et al.|Annals of Oncology|1994Cited by 259
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapyM. Marty, V. Stahalova, Marc Espié et al.|Annals of Oncology|2006Cited by 197
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC. Le Tourneau, Marie Dutreix, Brigitte Dréno et al.|British Journal of Cancer|2016Cited by 35
First-in-human phase I study of the DNA repair inhibitor DT01 in combination with radiotherapy in patients with in transit melanoma.Christophe Le Tourneau, Marie Dutreix, Brigitte Dréno et al.|Journal of Clinical Oncology|2015Cited by 1